Insight Molecular Diagnostics

IMDX

Börsenwert 92,9 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Broadwood Capital New York	16,7 Mio. $	–	–	–
2	2 Vanguard Group Malvern, Pennsylvania	1,66 Mio. $	+1,26 Mio. $	+11.157	+167 %
3	3 BlackRock New York	964.000 $	+97.061 $	+861	+9 %
4	AG 4 Artal Group Luxembourg	698.000 $	–	–	–
5	5 Bridgeway Capital Management Houston, Texas	674.000 $	–	–	–
6	6 Northern Trust Chicago, Illinois	205.000 $	+676 $	+6	+0,3 %
7	7 Destination Wealth Management Walnut Creek, California	138.000 $	–	–	–
8	8 Geode Capital Management Boston, Massachusetts	103.000 $	+902 $	+8	+0,7 %
9	9 Bank of New York Mellon New York	78.000 $	-1.578 $	-14	-2 %
10	10 Morgan Stanley New York	75.000 $	+34.834 $	+309	+63 %
11	11 New York State Common Retirement Fund Albany, New York	73.000 $	–	–	–
12	12 State Street Boston, Massachusetts	73.000 $	+89.621 $	+795	Neu
13	13 Susquehanna International Group Bala Cynwyd, Pennsylvania	48.000 $	+58.507 $	+519	Neu
14	14 Deutsche Bank Frankfurt Am Main Ge, Germany	39.000 $	+26.604 $	+236	+126 %
15	15 TIAA CREF Investment Management New York	34.000 $	–	–	–
16	16 California State Teachers Retirement System (CalSTRS) West Sacramento, California	30.000 $	–	–	–
17	17 UBS Group Zurich, Switzerland	24.000 $	+26.153 $	+232	+829 %
18	18 STRS Ohio Columbus, Ohio	21.000 $	–	–	–
19	19 Teachers Advisors New York	20.000 $	–	–	–
20	20 American International Group New York	12.000 $	+902 $	+8	+7 %
21	21 Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada	9.000 $	+225 $	+2	+2 %
22	22 Macquarie Group Sydney, NSW 2000, Australia	7.000 $	+7.891 $	+70	Neu
23	23 JP Morgan Chase New York	5.000 $	+5.975 $	+53	Neu
24	24 BNP Paribas Financial Markets Paris, France	3.469 $	+2.142 $	+19	+106 %
25	25 Carroll Financial Associates Charlotte, North Carolina	3.000 $	–	–	–

Insight Molecular Diagnostics IMDX Börsenwert 92,9 Mio. $

Insight Molecular Diagnostics

IMDX

Börsenwert 92,9 Mio. $